Dementia in AIDS patients: incidence and risk factors. Multicenter AIDS Cohort Study.
about
Cognitive neuropsychology of HIV-associated neurocognitive disordersImmune activation and inflammation in HIV-1 infection: causes and consequencesHIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictorsHuman CNS cultures exposed to HIV-1 gp120 reproduce dendritic injuries of HIV-1-associated dementiaCerebrospinal fluid HIV infection and pleocytosis: relation to systemic infection and antiretroviral treatmentHIV-associated neurocognitive disorder--pathogenesis and prospects for treatmentRole of Oxidative Stress in HIV-1-Associated Neurocognitive Disorder and Protection by Gene Delivery of Antioxidant EnzymesNeuropathogenesis of HIV-1-associated neurocognitive disorders: a possible involvement of D-serineMechanisms of HIV-1 Tat neurotoxicity via CDK5 translocation and hyper-activation: role in HIV-associated neurocognitive disordersHuman immunodeficiency virus type 1 and its coat protein gp120 induce apoptosis and activate JNK and ERK mitogen-activated protein kinases in human neuronsApoptotic death of striatal neurons induced by human immunodeficiency virus-1 Tat and gp120: Differential involvement of caspase-3 and endonuclease GMitochondria influence Fas expression in gp120-induced apoptosis of neuronal cellsFactors in AIDS dementia complex trial design: results and lessons from the abacavir trialHIV-1 infection of bone marrow hematopoietic progenitor cells and their role in trafficking and viral disseminationThe National NeuroAIDS Tissue Consortium (NNTC) Database: an integrated database for HIV-related studiesMonocyte/macrophage trafficking in acquired immunodeficiency syndrome encephalitis: lessons from human and nonhuman primate studiesHIV-1-associated neurocognitive disorder: epidemiology, pathogenesis, diagnosis, and treatment.The global security perspective on the effects of executive cognitive function on complex behavioral screening intervention and HIV/AIDS.Neurobehavioral alterations in HIV-1 transgenic rats: evidence for dopaminergic dysfunction.Rhesus macaque model of chronic opiate dependence and neuro-AIDS: longitudinal assessment of auditory brainstem responses and visual evoked potentialsCorrelation of acute humoral response with brain virus burden and survival time in pig-tailed macaques infected with the neurovirulent simian immunodeficiency virus SIVsmmFGbNormative scores for a brief neuropsychological battery for the detection of HIV-associated neurocognitive disorder (HAND) among South Africans.Menin mediates Tat-induced neuronal apoptosis in brain frontal cortex of SIV-infected macaques and in Tat-treated cells.Cerebrospinal fluid (CSF) biomarkers of iron status are associated with CSF viral load, antiretroviral therapy, and demographic factors in HIV-infected adults.Neurologic presentations of AIDS.Gene expression patterns associated with neurological disease in human HIV infectionBrain dysfunction in the era of combination antiretroviral therapy: implications for the treatment of the aging population of HIV-infected individualsCooperative induction of CXCL10 involves NADPH oxidase: Implications for HIV dementia.Chemokine receptor utilization by human immunodeficiency virus type 1 isolates that replicate in microglia.Neuronal death induced by brain-derived human immunodeficiency virus type 1 envelope genes differs between demented and nondemented AIDS patientsMethamphetamine abuse, HIV infection, and neurotoxicity.High viral load in the cerebrospinal fluid and brain correlates with severity of simian immunodeficiency virus encephalitis.Neurocognitive functioning in HIV-1 infection: effects of cerebrovascular risk factors and ageNeuropsychiatric aspects of HIV infection among older adults.What is the role of the HIV liaison psychiatrist?Implications of gliotransmission for the pharmacotherapy of CNS disorders.Methamphetamine toxicity and its implications during HIV-1 infection.Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline.Proteinuria is associated with neurocognitive impairment in antiretroviral therapy treated HIV-infected individualsHIV-associated neurocognitive disorder in HIV-infected Koreans: the Korean NeuroAIDS Project
P2860
Q22252615-E2205E8C-F6EF-4B95-9F08-63CAC0CD737CQ22252860-89655567-7F7A-45A4-87A3-0EB256E3C2ABQ24631745-D55E90B7-3913-4C43-9C8A-2FED397940EAQ24794489-80B1B4E2-ED82-44C6-AB56-FF768823EF6BQ24814874-4B4BFD64-F62B-407A-BEA2-0FC7A631B4A9Q26766448-E2DC3855-8262-48E1-8F16-80DE9215262DQ26829535-BC7C2A4B-85EE-4C6B-9092-0B5991575CB7Q27024914-030C79C2-65C9-43A2-925B-ED1B5157CB9FQ28082139-AC2627AB-AD4D-4079-82A6-5F8B45DF5BCCQ28256919-FE784C6F-3ABF-48D4-8AED-7BCBA0524DDEQ28267535-70B5235C-05D7-41FB-9A38-71550D3341B9Q28305896-997678E0-78A5-4ECF-990A-B0E09CDF93ABQ28469174-BBFD8128-09B2-4313-BE24-D7E0FD15101AQ28474374-BE0891D9-AFAC-4FAA-8036-9772184CE890Q28645981-0CFA970A-D70E-4BCE-B8BA-46CCA9393FD0Q28751900-774C96D7-6BB6-4D68-8D38-2AFDD6DE94FDQ30234305-03F60828-B786-4FB0-8CA7-D31D2A1BAC77Q30395989-71CBBF6F-712C-4303-90D8-3578EF4DDC96Q30445058-41926896-326C-48A4-B83D-D4334B32E0E0Q30452156-D899CF6E-B60F-4FB3-A906-7F3969F23DB3Q30478136-9DEF1CD9-63D6-4CB5-9AF3-EE008450DB36Q33533941-4C834DB3-D062-4D43-BF97-6942F430C59EQ33566813-A18BD660-B0C5-4AAC-8C70-92F072818415Q33587212-F48BE1F9-1859-4BD1-9BBF-FA3B12C73827Q33590337-42F91ACC-BD52-406F-9E50-ECDF24227741Q33605737-E1511376-D27B-425D-AF1E-3F4F943C69B3Q33614467-7E386C23-1531-4AFB-881A-DF37B7016593Q33647684-A23A4EC3-223B-4214-B23A-0435BB51DB39Q33782833-77E4642E-FFC3-4FF7-870E-335DDA93696AQ33785357-A5B79ACC-7190-41BE-8287-09AB31A5175EQ33799373-8172010C-300A-4986-B3D1-1DF180F5F121Q33825647-8EA15516-CB6C-42E9-B12C-3CCE190A0AF4Q33827518-FCD4F2FD-AC64-4B5D-B735-622EA4592650Q33827697-96377346-AD1A-46CA-ABE7-49A07D2C6FA5Q33937129-E131CA74-952A-4AB1-8BC7-E70EB1973041Q33971765-E3737B55-7CD1-46B0-9061-53778A6EE11EQ33985461-CEEE07E0-867D-410B-B37B-345C45205CB5Q33987146-662722A1-FA8F-4A9C-ABD6-6E47B2155CF5Q34048920-8C3EB285-1E01-4328-BF7A-FB6163503D9AQ34076133-6FFF097D-BA4C-40D6-A9AC-BC95390A62F8
P2860
Dementia in AIDS patients: incidence and risk factors. Multicenter AIDS Cohort Study.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh
1993年學術文章
@zh-hant
name
Dementia in AIDS patients: incidence and risk factors. Multicenter AIDS Cohort Study.
@en
type
label
Dementia in AIDS patients: incidence and risk factors. Multicenter AIDS Cohort Study.
@en
prefLabel
Dementia in AIDS patients: incidence and risk factors. Multicenter AIDS Cohort Study.
@en
P2093
P921
P356
P1433
P1476
Dementia in AIDS patients: incidence and risk factors. Multicenter AIDS Cohort Study
@en
P2093
D R Hoover
H Bacellar
J C McArthur
J H McArthur
J T Becker
L P Jacobson
N M Graham
O A Selnes
P304
P356
10.1212/WNL.43.11.2245
P407
P577
1993-11-01T00:00:00Z